How does lebrikizumab fit into proactive vs reactive AD treatment approaches?

Featuring Alexandra Golant, MD |

Medical Director, Dermatology Faculty Practice
Associate Director, Residency Program
Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, NY

| Published April 01, 2025

Loading...

Related CME

Dermsquared

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2025 dermsquared | All Rights Reserved